Amrana Qureshi
Overview
Explore the profile of Amrana Qureshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilson A, Moussa A, Trinquand A, Malone A, Tewari S, Calvert R, et al.
Br J Haematol
. 2024 Sep;
205(6):2355-2362.
PMID: 39327775
Early-phase trials of venetoclax in children and teenagers/young adults with leukaemia have yielded promising results, but there remains a paucity of real-world data. To address this, we report a cohort...
2.
Keren S, Lapira M, McCallum E, Sipkova Z, Qureshi A, Wilson S, et al.
Eye (Lond)
. 2022 Sep;
37(5):1002-1008.
PMID: 36171296
Objective: To describe a series of paediatric orbital lymphoma patients in a single tertiary referral centre. Methods: A retrospective case-note search in the Oxford Eye Hospital of all patients under...
3.
Charlesworth J, Wilson S, Qureshi A, Blanco E, Mitchell A, Segal S, et al.
Pediatr Blood Cancer
. 2021 Jun;
68(9):e29102.
PMID: 34114322
The cytokine storm of secondary haemophagocytic lymphohistiocytosis (sHLH)/macrophage activation syndrome (MAS) can cause life-threatening multiorgan failure. Interleukin-1 (IL-1) receptor blockade with anakinra can be effective in the management of sHLH/MAS....
4.
Brunelli N, Mohamed B, Fuschi M, Qureshi A, Mazzucco S
Neurol Sci
. 2021 Apr;
42(8):3449-3451.
PMID: 33890160
No abstract available.
5.
Ottaviano G, Baird S, Bonney D, Connor P, Cummins M, Evans P, et al.
Br J Haematol
. 2020 Nov;
192(2):e42-e44.
PMID: 33216967
No abstract available.
6.
Kavirayani A, Charlesworth J, Segal S, Kelly D, Wilson S, Qureshi A, et al.
Lancet Rheumatol
. 2020 Oct;
2(12):e736-e738.
PMID: 33083789
No abstract available.
7.
Moorman A, Schwab C, Winterman E, Hancock J, Castleton A, Cummins M, et al.
Br J Haematol
. 2020 Sep;
191(5):844-851.
PMID: 32926422
Patients with an ABL-class fusion have a high risk of relapse on standard chemotherapy but are sensitive to tyrosine kinase inhibitors (TKI). In UKALL2011, we screened patients with post-induction MRD...
8.
Holyome A, Cooper N, Qureshi A, Bain B
Am J Hematol
. 2020 May;
95(12):1614-1615.
PMID: 32419170
No abstract available.
9.
Qureshi A, Kaya B, Pancham S, Keenan R, Anderson J, Akanni M, et al.
Br J Haematol
. 2018 May;
181(4):460-475.
PMID: 29732531
No abstract available.
10.
Mazzucco S, Diomedi M, Qureshi A, Sainati L, Padayachee S
Int J Stroke
. 2017 Apr;
12(6):580-588.
PMID: 28440126
Background Sickle cell disease (SCD) is one of the most common causes of stroke in children worldwide. Based on the results of the Stroke Prevention Trial in Sickle Cell Anemia...